Peter Rahmer - Chief Corporate Development Officer at Relay Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Corporate Development Officer
Stock Symbol
RLAY on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Peter Rahmer - trading volume in the past year for Relay Therapeutics, Inc.

Holdings reported by Peter Rahmer for Relay Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 390K $2.36M $6.06 Oct 28, 2024 Direct

Transactions reported by Peter Rahmer for Relay Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.